Clinical Trial Update: Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 clinical trial evaluating autologous induced pluripotent stem cell-derived dopamine neurons transplanted into patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Penelope J. Hallett, Ph.D. | Conditions: Parkinson Disease | Phase 1 | Status: ENROLLING_BY_INVITATION